Variant report

Variant	esv3327833
Chromosome Location	chr11:45942401-45945249
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:318)
CpG islands
(count:551)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:318 , 50 per page) page: 1 2 3 4 5 6 7

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr11:45944870-45945146	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr11:45943360-45944159	H1-hESC	embryonic stem cell:	n/a	n/a
3	BHLHE40	chr11:45944747-45945001	K562	blood:	n/a	chr11:45944938-45944954
4	CCNT2	chr11:45943740-45944981	K562	blood:	n/a	chr11:45944138-45944147 chr11:45943905-45943914 chr11:45944108-45944117 chr11:45944015-45944024
5	CEBPD	chr11:45943603-45944444	HepG2	liver:	n/a	n/a
6	CHD1	chr11:45943257-45943813	H1-hESC	embryonic stem cell:	n/a	chr11:45943653-45943663
7	CHD1	chr11:45944355-45944552	H1-hESC	embryonic stem cell:	n/a	n/a
8	CHD2	chr11:45943781-45944105	HepG2	liver:	n/a	n/a
9	CHD2	chr11:45943804-45944315	K562	blood:	n/a	chr11:45944296-45944306 chr11:45944136-45944146
10	CHD2	chr11:45943548-45944107	H1-hESC	embryonic stem cell:	n/a	chr11:45943653-45943663
11	CHD2	chr11:45944638-45944763	K562	blood:	n/a	n/a
12	CHD2	chr11:45944988-45945098	HepG2	liver:	n/a	n/a
13	CREB1	chr11:45943672-45944301	H1-hESC	embryonic stem cell:	n/a	n/a
14	CREB1	chr11:45943613-45944143	H1-hESC	embryonic stem cell:	n/a	n/a
15	CTBP2	chr11:45942964-45944255	H1-hESC	embryonic stem cell:	n/a	n/a
16	CTCF	chr11:45944940-45945090	GM12871	blood:	n/a	n/a
17	CTCF	chr11:45944410-45944415	MCF-7	breast:	n/a	n/a
18	CTCF	chr11:45944360-45944510	SK-N-SH_RA	brain:	n/a	n/a
19	CTCF	chr11:45944820-45944970	HEEpiC	esophagus:	n/a	chr11:45944827-45944840
20	CTCF	chr11:45944320-45944470	HMEC	breast:	n/a	n/a
21	CTCF	chr11:45944740-45944890	Caco-2	colon:	n/a	chr11:45944827-45944840
22	CTCF	chr11:45944880-45945030	HCT-116	colon:	n/a	n/a
23	CTCF	chr11:45944340-45944490	SK-N-SH_RA	brain:	n/a	n/a
24	CTCF	chr11:45944960-45945110	AG04449	skin:	n/a	n/a
25	CTCF	chr11:45944419-45944430	MCF-7	breast:	n/a	n/a
26	CTCF	chr11:45944400-45944550	GM12874	blood:	n/a	n/a
27	CTCF	chr11:45944418-45944503	K562	blood:	n/a	n/a
28	CTCF	chr11:45944427-45944490	GM19238	blood:	n/a	n/a
29	CTCF	chr11:45942680-45942830	GM12873	blood:	n/a	n/a
30	CTCF	chr11:45944280-45944430	GM12871	blood:	n/a	n/a
31	CTCF	chr11:45944360-45944510	AG04449	skin:	n/a	n/a
32	CTCF	chr11:45944900-45945050	GM12873	blood:	n/a	n/a
33	CTCF	chr11:45944424-45944522	GM13977	blood:	n/a	n/a
34	CTCF	chr11:45944395-45944469	LNCaP	prostate:	n/a	n/a
35	CTCF	chr11:45944920-45945070	HMEC	breast:	n/a	n/a
36	CTCF	chr11:45944860-45945010	HRE	kidney:	n/a	n/a
37	CTCF	chr11:45944442-45944456	GM12892	blood:	n/a	n/a
38	CTCF	chr11:45944780-45944930	Caco-2	colon:	n/a	chr11:45944827-45944840
39	CTCF	chr11:45944930-45945089	K562	blood:	n/a	n/a
40	CTCF	chr11:45944860-45945010	HFF	foreskin:	n/a	n/a
41	CTCF	chr11:45944920-45945070	AoAF	blood vessel:	n/a	n/a
42	CTCF	chr11:45944780-45944930	GM12867	blood:	n/a	chr11:45944827-45944840
43	CTCF	chr11:45944900-45945050	GM12864	blood:	n/a	n/a
44	CTCF	chr11:45944250-45944550	K562	blood:	n/a	n/a
45	CTCF	chr11:45945090-45945093	GM12891	blood:	n/a	n/a
46	CTCF	chr11:45944423-45944455	GM10266	blood:	n/a	n/a
47	CTCF	chr11:45944360-45944510	NHLF	lung:	n/a	n/a
48	CTCF	chr11:45944193-45944635	K562	blood:	n/a	n/a
49	CTCF	chr11:45944900-45945050	K562	blood:	n/a	n/a
50	CTCF	chr11:45944948-45945032	H1-hESC	embryonic stem cell:	n/a	n/a

(count:551 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:45943130-45943180	AG04449	skin:	fetal
2	chr11:45943130-45943180	H1-hESC	embryonic stem cell:	embryo
3	chr11:45943130-45943180	AG04449	skin:	fetal
4	chr11:45943130-45943180	H1-hESC	embryonic stem cell:	embryo
5	chr11:45942789-45942839	HUVEC	blood vessel:	n/a
6	chr11:45944790-45944840	HCF	heart:	n/a
7	chr11:45942789-45942839	LNCaP	prostate:	n/a
8	chr11:45944076-45944126	PrEC	prostate:	n/a
9	chr11:45944076-45944126	H1-hESC	embryonic stem cell:	embryo
10	chr11:45943572-45943622	HAEpiC	amniotic membrane:	n/a
11	chr11:45943979-45944029	NB4	blood:	n/a
12	chr11:45944076-45944126	NT2-D1	testis:	n/a
13	chr11:45943130-45943180	SK-N-SH	brain:	n/a
14	chr11:45944790-45944840	NHBE	bronchial:	n/a
15	chr11:45943979-45944029	BJ	skin:	n/a
16	chr11:45943237-45943287	AG09319	gingival:	n/a
17	chr11:45944076-45944126	HCT-116	colon:	n/a
18	chr11:45943979-45944029	PANC-1	pancreas:	n/a
19	chr11:45944076-45944126	AG10803	skin:	n/a
20	chr11:45943237-45943287	SK-N-MC	brain:	n/a
21	chr11:45943572-45943622	ECC-1	luminal epithelium:	n/a
22	chr11:45944790-45944840	PANC-1	pancreas:	n/a
23	chr11:45943572-45943622	SK-N-SH_RA	brain:	n/a
24	chr11:45942789-45942839	HCT-116	colon:	n/a
25	chr11:45944076-45944126	AG09309	skin:	n/a
26	chr11:45944091-45944141	IMR90	lung:	fetal
27	chr11:45943237-45943287	SAEC	small airway:	n/a
28	chr11:45944790-45944840	ECC-1	luminal epithelium:	n/a
29	chr11:45943979-45944029	Hela-S3	cervix:	n/a
30	chr11:45944790-45944840	SK-N-SH	brain:	n/a
31	chr11:45943130-45943180	AG09319	gingival:	n/a
32	chr11:45944091-45944141	Caco-2	colon:	n/a
33	chr11:45944790-45944840	A549	lung:	n/a
34	chr11:45942789-45942839	HEK293	kidney:	embryo
35	chr11:45944790-45944840	SK-N-SH_RA	brain:	n/a
36	chr11:45944076-45944126	GM19239	blood:	n/a
37	chr11:45944790-45944840	AoSMC	blood vessel:	n/a
38	chr11:45944076-45944126	SAEC	small airway:	n/a
39	chr11:45942789-45942839	ProgFib	skin:	n/a
40	chr11:45943130-45943180	IMR90	lung:	fetal
41	chr11:45942789-45942839	GM19239	blood:	n/a
42	chr11:45944790-45944840	U87	brain:	n/a
43	chr11:45944790-45944840	SKMC	muscle:	n/a
44	chr11:45944091-45944141	SAEC	small airway:	n/a
45	chr11:45943979-45944029	PrEC	prostate:	n/a
46	chr11:45942789-45942839	HRPEpiC	eye:	n/a
47	chr11:45944790-45944840	HAEpiC	amniotic membrane:	n/a
48	chr11:45943979-45944029	Jurkat	blood:	n/a
49	chr11:45944920-45944970	RPTEC	kidney:	n/a
50	chr11:45943237-45943287	T-47D	breast:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:45942684..45944705-chr11:46141351..46143147,2	K562	blood:
2	chr11:45879680..45881437-chr11:45942342..45944046,2	MCF-7	breast:
3	chr11:45942020..45943576-chr11:46141975..46144467,2	MCF-7	breast:
4	chr11:45944787..45946706-chr11:45959461..45962306,2	K562	blood:
5	chr11:45944749..45946540-chr11:45946715..45948340,2	K562	blood:
6	chr11:45867151..45870859-chr11:45942545..45946514,4	K562	blood:
7	chr11:45943430..45944211-chr5:39074478..39074986,2	HCT-116	colon:
8	chr11:45868765..45870683-chr11:45944601..45946304,2	MCF-7	breast:

No data

Variant related genes	Relation type
GYLTL1B	TF binding region
PEX16	TF binding region
GYLTL1B	CpG island
PEX16	CpG island
ENSG00000121671	chromatin interactions
ENSG00000165905	chromatin interactions
ENSG00000164327	chromatin interactions
ENSG00000135365	chromatin interactions

Extended variants
information (count: 108 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:108 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs564216220	chr11:45942424-45942425	Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs12574430	chr11:45942485-45942486	Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs533293730	chr11:45942512-45942513	Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs182960103	chr11:45942522-45942523	Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs569857269	chr11:45942523-45942524	Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs538890629	chr11:45942539-45942540	Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs368624485	chr11:45942540-45942541	Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs372352111	chr11:45942558-45942559	Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs145577771	chr11:45942564-45942565	Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs549077361	chr11:45942565-45942566	Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs565879048	chr11:45942751-45942752	Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs531633401	chr11:45942758-45942759	Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs558165537	chr11:45942789-45942790	Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs549748120	chr11:45942790-45942791	Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs35137569	chr11:45942791-45942792	Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs537770101	chr11:45942887-45942888	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs557237495	chr11:45942899-45942900	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs574293065	chr11:45942914-45942915	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs541899310	chr11:45942922-45942923	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs561764128	chr11:45942927-45942928	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs572212606	chr11:45942943-45942944	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs10838530	chr11:45942995-45942996	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs577618423	chr11:45943071-45943072	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs564138407	chr11:45943112-45943113	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs533052509	chr11:45943127-45943128	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs12804463	chr11:45943129-45943130	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs563301698	chr11:45943161-45943162	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs529048381	chr11:45943204-45943205	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs537943108	chr11:45943267-45943268	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs115184899	chr11:45943272-45943273	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs565817639	chr11:45943353-45943354	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs7120427	chr11:45943368-45943369	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs369342285	chr11:45943422-45943423	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs571630105	chr11:45943434-45943435	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs147707585	chr11:45943436-45943437	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs557637688	chr11:45943442-45943443	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs575008030	chr11:45943446-45943447	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs7123789	chr11:45943460-45943461	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs201273844	chr11:45943481-45943482	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs142648947	chr11:45943516-45943517	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs76205096	chr11:45943517-45943518	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs7123821	chr11:45943539-45943540	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs191094968	chr11:45943666-45943667	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs541135453	chr11:45943678-45943679	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs563895792	chr11:45943688-45943689	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs577567730	chr11:45943704-45943705	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs543308894	chr11:45943722-45943723	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
48	rs78936409	chr11:45943735-45943736	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs12806008	chr11:45943744-45943745	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs7342255	chr11:45943819-45943820	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Parathyroid adenoma	22454399	CNVD
Medulloblastoma	21979893	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Medulloblastoma	16783165	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Chordoma	18071362	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21364760	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
small cell lung cancer	20016488	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Myelofibrosis	22110671	CNVD
Melanoma	18172304	CNVD
Intracranial ependymoma	16609018	CNVD
Myxofibrosarcoma	16751306	CNVD
Potocki-Shaffer syndrome	22470819	CNVD
Neurodevelopmental disorder	22521361	CNVD
Breast cancer	16608533	CNVD
Hirschsprung''s Disease	21712996	CNVD
Follicular lymphoma	20505157	CNVD
Colorectal cancer	21128281	CNVD
Breast cancer	20409316	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17160897	CNVD
Mantle cell lymphoma	19029149	CNVD
Glioblastoma multiforme	21138945	CNVD
Prostate cancer	18632612	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:477 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:45940400-45943000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr11:45940400-45943400	Weak transcription	Fetal Heart	heart
3	chr11:45940400-45943600	Weak transcription	Lung	lung
4	chr11:45940400-45943800	Weak transcription	Aorta	Aorta
5	chr11:45940600-45942600	Weak transcription	Fetal Lung	lung
6	chr11:45940600-45943000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
7	chr11:45940600-45943000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
8	chr11:45940600-45943000	Weak transcription	Rectal Mucosa Donor 31	rectum
9	chr11:45940600-45943200	Enhancers	Breast Myoepithelial Primary Cells	Breast
10	chr11:45940600-45943200	Weak transcription	Ovary	ovary
11	chr11:45940600-45943400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
12	chr11:45940600-45943400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
13	chr11:45940600-45943400	Weak transcription	Pancreatic Islets	Pancreatic Islet
14	chr11:45940600-45943400	Weak transcription	HMEC	breast
15	chr11:45940600-45943600	Enhancers	Cortex derived primary cultured neurospheres	brain
16	chr11:45940600-45943600	Enhancers	Brain Substantia Nigra	brain
17	chr11:45940600-45943600	Enhancers	K562	blood
18	chr11:45940600-45943600	Weak transcription	NHEK	skin
19	chr11:45940800-45942600	Weak transcription	Fetal Kidney	kidney
20	chr11:45940800-45943200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
21	chr11:45941000-45943400	Enhancers	Primary B cells from cord blood	blood
22	chr11:45941000-45943400	Enhancers	Primary T helper cells fromperipheralblood	blood
23	chr11:45941000-45943400	Weak transcription	Liver	Liver
24	chr11:45941000-45943600	Enhancers	Primary B cells from peripheral blood	blood
25	chr11:45941000-45943600	Weak transcription	Right Ventricle	heart
26	chr11:45941000-45943800	Weak transcription	Right Atrium	heart
27	chr11:45941200-45942800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr11:45941200-45942800	Weak transcription	Psoas Muscle	Psoas
29	chr11:45941200-45943000	Weak transcription	Gastric	stomach
30	chr11:45941200-45943400	Weak transcription	Left Ventricle	heart
31	chr11:45941200-45943400	Weak transcription	Spleen	Spleen
32	chr11:45941200-45943600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
33	chr11:45941200-45944000	Weak transcription	Primary T killer memory cells from peripheral blood	blood
34	chr11:45941200-45953400	Weak transcription	Dnd41	blood
35	chr11:45941400-45942600	Enhancers	Fetal Intestine Small	intestine
36	chr11:45941600-45943000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr11:45941600-45943000	Enhancers	HUES48 Cell Line	embryonic stem cell
38	chr11:45941600-45943000	Enhancers	Brain Anterior Caudate	brain
39	chr11:45941600-45943000	Enhancers	Placenta	Placenta
40	chr11:45941600-45943200	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr11:45941600-45943200	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
42	chr11:45941600-45943400	Enhancers	Pancreas	Pancrea
43	chr11:45941800-45942800	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
44	chr11:45941800-45942800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
45	chr11:45941800-45943000	Weak transcription	Primary T helper naive cells from peripheral blood	blood
46	chr11:45941800-45943200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
47	chr11:45941800-45943400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
48	chr11:45941800-45943400	Weak transcription	Brain Cingulate Gyrus	brain
49	chr11:45942000-45942800	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
50	chr11:45942000-45943000	Enhancers	H9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links